nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—Angioedema—Mycophenolate mofetil—psoriasis	0.000647	0.00106	CcSEcCtD
Hydroxocobalamin—Erythema—Hydrocortisone—psoriasis	0.000645	0.00106	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Mycophenolic acid—psoriasis	0.000645	0.00106	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Hydroxyurea—psoriasis	0.000644	0.00105	CcSEcCtD
Hydroxocobalamin—Malaise—Mycophenolate mofetil—psoriasis	0.000639	0.00105	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000632	0.00103	CcSEcCtD
Hydroxocobalamin—Pain—Mycophenolic acid—psoriasis	0.000626	0.00103	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Triamcinolone—psoriasis	0.000624	0.00102	CcSEcCtD
Hydroxocobalamin—Chest pain—Cyclosporine—psoriasis	0.000618	0.00101	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000614	0.001	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Prednisolone—psoriasis	0.000613	0.001	CcSEcCtD
Hydroxocobalamin—Discomfort—Cyclosporine—psoriasis	0.000611	0.001	CcSEcCtD
Hydroxocobalamin—Erythema—Triamcinolone—psoriasis	0.000608	0.000994	CcSEcCtD
Hydroxocobalamin—Angioedema—Prednisolone—psoriasis	0.000604	0.000988	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Mycophenolic acid—psoriasis	0.000604	0.000988	CcSEcCtD
Hydroxocobalamin—Chest pain—Mycophenolate mofetil—psoriasis	0.000603	0.000987	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000599	0.00098	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Hydrocortisone—psoriasis	0.000599	0.00098	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Hydroxyurea—psoriasis	0.000598	0.000979	CcSEcCtD
Hydroxocobalamin—Malaise—Prednisolone—psoriasis	0.000596	0.000975	CcSEcCtD
Hydroxocobalamin—Discomfort—Mycophenolate mofetil—psoriasis	0.000596	0.000975	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Cyclosporine—psoriasis	0.000593	0.00097	CcSEcCtD
Hydroxocobalamin—Oedema—Cyclosporine—psoriasis	0.000593	0.00097	CcSEcCtD
Hydroxocobalamin—Eye disorder—Dexamethasone—psoriasis	0.000592	0.000969	CcSEcCtD
Hydroxocobalamin—Eye disorder—Betamethasone—psoriasis	0.000592	0.000969	CcSEcCtD
Hydroxocobalamin—Angioedema—Hydrocortisone—psoriasis	0.00059	0.000965	CcSEcCtD
Hydroxocobalamin—Infection—Cyclosporine—psoriasis	0.000589	0.000963	CcSEcCtD
Hydroxocobalamin—Malaise—Hydrocortisone—psoriasis	0.000582	0.000952	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Cyclosporine—psoriasis	0.000581	0.000951	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Mycophenolic acid—psoriasis	0.000579	0.000948	CcSEcCtD
Hydroxocobalamin—Dizziness—Hydroxyurea—psoriasis	0.000578	0.000946	CcSEcCtD
Hydroxocobalamin—Oedema—Mycophenolate mofetil—psoriasis	0.000578	0.000946	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000578	0.000946	CcSEcCtD
Hydroxocobalamin—Skin disorder—Cyclosporine—psoriasis	0.000576	0.000942	CcSEcCtD
Hydroxocobalamin—Angiopathy—Dexamethasone—psoriasis	0.000575	0.00094	CcSEcCtD
Hydroxocobalamin—Angiopathy—Betamethasone—psoriasis	0.000575	0.00094	CcSEcCtD
Hydroxocobalamin—Infection—Mycophenolate mofetil—psoriasis	0.000574	0.00094	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000567	0.000928	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Dexamethasone—psoriasis	0.000566	0.000926	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Betamethasone—psoriasis	0.000566	0.000926	CcSEcCtD
Hydroxocobalamin—Tachycardia—Mycophenolate mofetil—psoriasis	0.000564	0.000923	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Triamcinolone—psoriasis	0.000564	0.000923	CcSEcCtD
Hydroxocobalamin—Skin disorder—Mycophenolate mofetil—psoriasis	0.000562	0.000919	CcSEcCtD
Hydroxocobalamin—Discomfort—Prednisolone—psoriasis	0.000556	0.00091	CcSEcCtD
Hydroxocobalamin—Angioedema—Triamcinolone—psoriasis	0.000555	0.000909	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Methotrexate—psoriasis	0.000552	0.000903	CcSEcCtD
Hydroxocobalamin—Rash—Hydroxyurea—psoriasis	0.000552	0.000902	CcSEcCtD
Hydroxocobalamin—Erythema—Dexamethasone—psoriasis	0.000551	0.000902	CcSEcCtD
Hydroxocobalamin—Erythema—Betamethasone—psoriasis	0.000551	0.000902	CcSEcCtD
Hydroxocobalamin—Dermatitis—Hydroxyurea—psoriasis	0.000551	0.000902	CcSEcCtD
Hydroxocobalamin—Malaise—Triamcinolone—psoriasis	0.000548	0.000897	CcSEcCtD
Hydroxocobalamin—Headache—Hydroxyurea—psoriasis	0.000548	0.000897	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000546	0.000893	CcSEcCtD
Hydroxocobalamin—Discomfort—Hydrocortisone—psoriasis	0.000543	0.000888	CcSEcCtD
Hydroxocobalamin—Oedema—Prednisolone—psoriasis	0.000539	0.000882	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Prednisolone—psoriasis	0.000539	0.000882	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Cyclosporine—psoriasis	0.000528	0.000865	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Hydrocortisone—psoriasis	0.000527	0.000862	CcSEcCtD
Hydroxocobalamin—Oedema—Hydrocortisone—psoriasis	0.000527	0.000862	CcSEcCtD
Hydroxocobalamin—Tachycardia—Prednisolone—psoriasis	0.000526	0.000861	CcSEcCtD
Hydroxocobalamin—Infection—Hydrocortisone—psoriasis	0.000523	0.000856	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Cyclosporine—psoriasis	0.000522	0.000854	CcSEcCtD
Hydroxocobalamin—Nausea—Hydroxyurea—psoriasis	0.00052	0.00085	CcSEcCtD
Hydroxocobalamin—Pruritus—Mycophenolic acid—psoriasis	0.000518	0.000848	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Hydrocortisone—psoriasis	0.000517	0.000845	CcSEcCtD
Hydroxocobalamin—Eye disorder—Prednisone—psoriasis	0.000516	0.000844	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000515	0.000843	CcSEcCtD
Hydroxocobalamin—Tachycardia—Hydrocortisone—psoriasis	0.000514	0.000841	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000512	0.000837	CcSEcCtD
Hydroxocobalamin—Skin disorder—Hydrocortisone—psoriasis	0.000512	0.000837	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Betamethasone—psoriasis	0.000512	0.000837	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Dexamethasone—psoriasis	0.000512	0.000837	CcSEcCtD
Hydroxocobalamin—Discomfort—Triamcinolone—psoriasis	0.000511	0.000836	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000509	0.000833	CcSEcCtD
Hydroxocobalamin—Pain—Cyclosporine—psoriasis	0.000507	0.000829	CcSEcCtD
Hydroxocobalamin—Angioedema—Betamethasone—psoriasis	0.000504	0.000824	CcSEcCtD
Hydroxocobalamin—Angioedema—Dexamethasone—psoriasis	0.000504	0.000824	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Mycophenolic acid—psoriasis	0.000501	0.00082	CcSEcCtD
Hydroxocobalamin—Angiopathy—Prednisone—psoriasis	0.0005	0.000819	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000499	0.000817	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Prednisone—psoriasis	0.000498	0.000815	CcSEcCtD
Hydroxocobalamin—Malaise—Dexamethasone—psoriasis	0.000497	0.000814	CcSEcCtD
Hydroxocobalamin—Malaise—Betamethasone—psoriasis	0.000497	0.000814	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Triamcinolone—psoriasis	0.000496	0.000812	CcSEcCtD
Hydroxocobalamin—Oedema—Triamcinolone—psoriasis	0.000496	0.000812	CcSEcCtD
Hydroxocobalamin—Pain—Mycophenolate mofetil—psoriasis	0.000494	0.000809	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Prednisone—psoriasis	0.000493	0.000806	CcSEcCtD
Hydroxocobalamin—Infection—Triamcinolone—psoriasis	0.000493	0.000806	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Cyclosporine—psoriasis	0.000488	0.000799	CcSEcCtD
Hydroxocobalamin—Dizziness—Mycophenolic acid—psoriasis	0.000484	0.000793	CcSEcCtD
Hydroxocobalamin—Tachycardia—Triamcinolone—psoriasis	0.000484	0.000792	CcSEcCtD
Hydroxocobalamin—Mental disorder—Prednisone—psoriasis	0.000483	0.000791	CcSEcCtD
Hydroxocobalamin—CASP9—DNA Damage Response—TP53—psoriasis	0.000482	0.00124	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—TYK2—psoriasis	0.000482	0.00124	CbGpPWpGaD
Hydroxocobalamin—Erythema—Prednisone—psoriasis	0.00048	0.000786	CcSEcCtD
Hydroxocobalamin—MTR—Selenium Micronutrient Network—IL6—psoriasis	0.000477	0.00123	CbGpPWpGaD
Hydroxocobalamin—CASP9—p75(NTR)-mediated signaling—TP53—psoriasis	0.000477	0.00123	CbGpPWpGaD
Hydroxocobalamin—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000476	0.00078	CcSEcCtD
Hydroxocobalamin—CASP9—B Cell Activation—NFKBIA—psoriasis	0.000474	0.00122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—TYK2—psoriasis	0.000474	0.00122	CbGpPWpGaD
Hydroxocobalamin—Urticaria—Cyclosporine—psoriasis	0.000471	0.00077	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Cyclosporine—psoriasis	0.000469	0.000767	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—ITGAL—psoriasis	0.000466	0.0012	CbGpPWpGaD
Hydroxocobalamin—CASP9—miRNA Regulation of DNA Damage Response—TP53—psoriasis	0.000466	0.0012	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000465	0.00119	CbGpPWpGaD
Hydroxocobalamin—Discomfort—Dexamethasone—psoriasis	0.000464	0.000759	CcSEcCtD
Hydroxocobalamin—Discomfort—Betamethasone—psoriasis	0.000464	0.000759	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Hydrocortisone—psoriasis	0.000464	0.000759	CcSEcCtD
Hydroxocobalamin—Rash—Mycophenolic acid—psoriasis	0.000462	0.000756	CcSEcCtD
Hydroxocobalamin—CASP9—Apoptosis—TNF—psoriasis	0.000462	0.00119	CbGpPWpGaD
Hydroxocobalamin—Dermatitis—Mycophenolic acid—psoriasis	0.000461	0.000755	CcSEcCtD
Hydroxocobalamin—Pain—Prednisolone—psoriasis	0.000461	0.000755	CcSEcCtD
Hydroxocobalamin—Urticaria—Mycophenolate mofetil—psoriasis	0.000459	0.000752	CcSEcCtD
Hydroxocobalamin—Headache—Mycophenolic acid—psoriasis	0.000459	0.000751	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000457	0.000748	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Methotrexate—psoriasis	0.000455	0.000745	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000455	0.000744	CcSEcCtD
Hydroxocobalamin—AMN—Metabolism—CARM1—psoriasis	0.000454	0.00117	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—CARM1—psoriasis	0.000454	0.00117	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—TYK2—psoriasis	0.000453	0.00116	CbGpPWpGaD
Hydroxocobalamin—Urethral disorder—Methotrexate—psoriasis	0.000452	0.000739	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by FGFR—TYK2—psoriasis	0.000451	0.00116	CbGpPWpGaD
Hydroxocobalamin—Pain—Hydrocortisone—psoriasis	0.00045	0.000737	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Betamethasone—psoriasis	0.00045	0.000736	CcSEcCtD
Hydroxocobalamin—Oedema—Betamethasone—psoriasis	0.00045	0.000736	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Dexamethasone—psoriasis	0.00045	0.000736	CcSEcCtD
Hydroxocobalamin—Oedema—Dexamethasone—psoriasis	0.00045	0.000736	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by ERBB2—TYK2—psoriasis	0.000448	0.00115	CbGpPWpGaD
Hydroxocobalamin—Infection—Betamethasone—psoriasis	0.000447	0.000732	CcSEcCtD
Hydroxocobalamin—Infection—Dexamethasone—psoriasis	0.000447	0.000732	CcSEcCtD
Hydroxocobalamin—CASP9—DAP12 signaling—TYK2—psoriasis	0.000446	0.00115	CbGpPWpGaD
Hydroxocobalamin—Ill-defined disorder—Prednisone—psoriasis	0.000446	0.000729	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Prednisolone—psoriasis	0.000444	0.000727	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Triamcinolone—psoriasis	0.000442	0.000724	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Dexamethasone—psoriasis	0.000441	0.000722	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Betamethasone—psoriasis	0.000441	0.000722	CcSEcCtD
Hydroxocobalamin—Agitation—Prednisone—psoriasis	0.000441	0.000722	CcSEcCtD
Hydroxocobalamin—CASP9—Innate Immune System—IFIH1—psoriasis	0.000441	0.00113	CbGpPWpGaD
Hydroxocobalamin—Tachycardia—Betamethasone—psoriasis	0.000439	0.000719	CcSEcCtD
Hydroxocobalamin—Tachycardia—Dexamethasone—psoriasis	0.000439	0.000719	CcSEcCtD
Hydroxocobalamin—Angioedema—Prednisone—psoriasis	0.000439	0.000718	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Cyclosporine—psoriasis	0.000437	0.000715	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Triamcinolone—psoriasis	0.000437	0.000714	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—REL—psoriasis	0.000436	0.00112	CbGpPWpGaD
Hydroxocobalamin—Nausea—Mycophenolic acid—psoriasis	0.000435	0.000712	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Hydrocortisone—psoriasis	0.000434	0.00071	CcSEcCtD
Hydroxocobalamin—Malaise—Prednisone—psoriasis	0.000433	0.000709	CcSEcCtD
Hydroxocobalamin—MUT—Metabolism—CARM1—psoriasis	0.000433	0.00111	CbGpPWpGaD
Hydroxocobalamin—Eye disorder—Methotrexate—psoriasis	0.000431	0.000705	CcSEcCtD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—TNF—psoriasis	0.000429	0.0011	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000429	0.0011	CbGpPWpGaD
Hydroxocobalamin—Urticaria—Prednisolone—psoriasis	0.000428	0.000701	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Methotrexate—psoriasis	0.000428	0.0007	CcSEcCtD
Hydroxocobalamin—CASP9—Alzheimers Disease—TP53—psoriasis	0.000428	0.0011	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000426	0.000697	CcSEcCtD
Hydroxocobalamin—AMN—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000424	0.00109	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000424	0.00109	CbGpPWpGaD
Hydroxocobalamin—Pain—Triamcinolone—psoriasis	0.000424	0.000694	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—ERAP1—psoriasis	0.000424	0.00109	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—TYK2—psoriasis	0.00042	0.00108	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—TYK2—psoriasis	0.00042	0.00108	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—TYK2—psoriasis	0.00042	0.00108	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Cyclosporine—psoriasis	0.000419	0.000686	CcSEcCtD
Hydroxocobalamin—Urticaria—Hydrocortisone—psoriasis	0.000418	0.000685	CcSEcCtD
Hydroxocobalamin—Angiopathy—Methotrexate—psoriasis	0.000418	0.000684	CcSEcCtD
Hydroxocobalamin—CASP9—Innate Immune System—HLA-C—psoriasis	0.000418	0.00107	CbGpPWpGaD
Hydroxocobalamin—Immune system disorder—Methotrexate—psoriasis	0.000416	0.000681	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Hydrocortisone—psoriasis	0.000416	0.000681	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR—TYK2—psoriasis	0.000416	0.00107	CbGpPWpGaD
Hydroxocobalamin—Mediastinal disorder—Methotrexate—psoriasis	0.000415	0.00068	CcSEcCtD
Hydroxocobalamin—Chills—Methotrexate—psoriasis	0.000414	0.000677	CcSEcCtD
Hydroxocobalamin—CASP9—Innate Immune System—TNFAIP3—psoriasis	0.000413	0.00106	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—TYK2—psoriasis	0.000412	0.00106	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—TYK2—psoriasis	0.00041	0.00106	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Mycophenolate mofetil—psoriasis	0.000409	0.000669	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Triamcinolone—psoriasis	0.000409	0.000669	CcSEcCtD
Hydroxocobalamin—CASP9—Apoptosis—TP53—psoriasis	0.000407	0.00105	CbGpPWpGaD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000406	0.000664	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Cyclosporine—psoriasis	0.000406	0.000664	CcSEcCtD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000405	0.00104	CbGpPWpGaD
Hydroxocobalamin—Discomfort—Prednisone—psoriasis	0.000404	0.000661	CcSEcCtD
Hydroxocobalamin—Mental disorder—Methotrexate—psoriasis	0.000404	0.000661	CcSEcCtD
Hydroxocobalamin—Erythema—Methotrexate—psoriasis	0.000401	0.000657	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—HLA-C—psoriasis	0.000401	0.00103	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—CARM1—psoriasis	0.0004	0.00103	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Prednisolone—psoriasis	0.000397	0.00065	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Dexamethasone—psoriasis	0.000396	0.000648	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Betamethasone—psoriasis	0.000396	0.000648	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000396	0.000647	CcSEcCtD
Hydroxocobalamin—Urticaria—Triamcinolone—psoriasis	0.000394	0.000645	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Triamcinolone—psoriasis	0.000392	0.000642	CcSEcCtD
Hydroxocobalamin—Dizziness—Cyclosporine—psoriasis	0.000392	0.000641	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Prednisone—psoriasis	0.000392	0.000641	CcSEcCtD
Hydroxocobalamin—Oedema—Prednisone—psoriasis	0.000392	0.000641	CcSEcCtD
Hydroxocobalamin—Infection—Prednisone—psoriasis	0.000389	0.000637	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Betamethasone—psoriasis	0.000389	0.000636	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000389	0.000636	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Hydrocortisone—psoriasis	0.000388	0.000635	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—JUN—psoriasis	0.000386	0.000992	CbGpPWpGaD
Hydroxocobalamin—Pain—Dexamethasone—psoriasis	0.000385	0.00063	CcSEcCtD
Hydroxocobalamin—Pain—Betamethasone—psoriasis	0.000385	0.00063	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Prednisone—psoriasis	0.000384	0.000629	CcSEcCtD
Hydroxocobalamin—Tachycardia—Prednisone—psoriasis	0.000382	0.000626	CcSEcCtD
Hydroxocobalamin—Dizziness—Mycophenolate mofetil—psoriasis	0.000382	0.000626	CcSEcCtD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—TP53—psoriasis	0.000382	0.000982	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HCAR2—psoriasis	0.000381	0.00098	CbGpPWpGaD
Hydroxocobalamin—Skin disorder—Prednisone—psoriasis	0.000381	0.000623	CcSEcCtD
Hydroxocobalamin—Rash—Cyclosporine—psoriasis	0.000374	0.000611	CcSEcCtD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000373	0.00096	CbGpPWpGaD
Hydroxocobalamin—Dermatitis—Cyclosporine—psoriasis	0.000373	0.000611	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—DDX58—psoriasis	0.000373	0.000959	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Hydrocortisone—psoriasis	0.000373	0.00061	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Methotrexate—psoriasis	0.000372	0.000609	CcSEcCtD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—TYK2—psoriasis	0.000372	0.000956	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—NFKB1—psoriasis	0.000371	0.000955	CbGpPWpGaD
Hydroxocobalamin—Headache—Cyclosporine—psoriasis	0.000371	0.000608	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Dexamethasone—psoriasis	0.000371	0.000607	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Betamethasone—psoriasis	0.000371	0.000607	CcSEcCtD
Hydroxocobalamin—MMACHC—Metabolism—CAT—psoriasis	0.000368	0.000947	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—HLA-A—psoriasis	0.000366	0.000941	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Triamcinolone—psoriasis	0.000365	0.000598	CcSEcCtD
Hydroxocobalamin—Rash—Mycophenolate mofetil—psoriasis	0.000365	0.000596	CcSEcCtD
Hydroxocobalamin—Dermatitis—Mycophenolate mofetil—psoriasis	0.000364	0.000596	CcSEcCtD
Hydroxocobalamin—Headache—Mycophenolate mofetil—psoriasis	0.000362	0.000593	CcSEcCtD
Hydroxocobalamin—Malaise—Methotrexate—psoriasis	0.000362	0.000592	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Hydrocortisone—psoriasis	0.00036	0.00059	CcSEcCtD
Hydroxocobalamin—Urticaria—Dexamethasone—psoriasis	0.000358	0.000585	CcSEcCtD
Hydroxocobalamin—Urticaria—Betamethasone—psoriasis	0.000358	0.000585	CcSEcCtD
Hydroxocobalamin—Dizziness—Prednisolone—psoriasis	0.000357	0.000584	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Dexamethasone—psoriasis	0.000356	0.000582	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Betamethasone—psoriasis	0.000356	0.000582	CcSEcCtD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—JUN—psoriasis	0.000354	0.000911	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—STAT3—psoriasis	0.000353	0.000907	CbGpPWpGaD
Hydroxocobalamin—Nausea—Cyclosporine—psoriasis	0.000352	0.000576	CcSEcCtD
Hydroxocobalamin—Pruritus—Triamcinolone—psoriasis	0.000351	0.000574	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by NGF—NFKBIA—psoriasis	0.000349	0.000898	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Hydrocortisone—psoriasis	0.000348	0.00057	CcSEcCtD
Hydroxocobalamin—CASP9—Innate Immune System—HLA-E—psoriasis	0.000347	0.000892	CbGpPWpGaD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—IL6—psoriasis	0.000347	0.000891	CbGpPWpGaD
Hydroxocobalamin—Dyspepsia—Prednisone—psoriasis	0.000345	0.000564	CcSEcCtD
Hydroxocobalamin—Nausea—Mycophenolate mofetil—psoriasis	0.000343	0.000562	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—psoriasis	0.000343	0.000881	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—APOE—psoriasis	0.000342	0.000879	CbGpPWpGaD
Hydroxocobalamin—Chest pain—Methotrexate—psoriasis	0.000342	0.000559	CcSEcCtD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—NFKB1—psoriasis	0.000341	0.000877	CbGpPWpGaD
Hydroxocobalamin—Rash—Prednisolone—psoriasis	0.00034	0.000556	CcSEcCtD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—JUN—psoriasis	0.00034	0.000874	CbGpPWpGaD
Hydroxocobalamin—Dermatitis—Prednisolone—psoriasis	0.00034	0.000556	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000339	0.000555	CcSEcCtD
Hydroxocobalamin—Headache—Prednisolone—psoriasis	0.000338	0.000553	CcSEcCtD
Hydroxocobalamin—Discomfort—Methotrexate—psoriasis	0.000338	0.000552	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—VEGFA—psoriasis	0.000337	0.000867	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—CAT—psoriasis	0.000337	0.000866	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—CAT—psoriasis	0.000337	0.000866	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—HLA-A—psoriasis	0.000335	0.000861	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—HLA-A—psoriasis	0.000335	0.000861	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HLA-E—psoriasis	0.000333	0.000856	CbGpPWpGaD
Hydroxocobalamin—Rash—Hydrocortisone—psoriasis	0.000332	0.000543	CcSEcCtD
Hydroxocobalamin—Dermatitis—Hydrocortisone—psoriasis	0.000332	0.000543	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling Pathways—TAGAP—psoriasis	0.000331	0.00085	CbGpPWpGaD
Hydroxocobalamin—Headache—Hydrocortisone—psoriasis	0.00033	0.00054	CcSEcCtD
Hydroxocobalamin—MTRR—Metabolism—CARM1—psoriasis	0.000328	0.000844	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Triamcinolone—psoriasis	0.000328	0.000537	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Methotrexate—psoriasis	0.000328	0.000536	CcSEcCtD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—NFKB1—psoriasis	0.000327	0.000841	CbGpPWpGaD
Hydroxocobalamin—Infection—Methotrexate—psoriasis	0.000325	0.000532	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Prednisone—psoriasis	0.000323	0.000528	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Methotrexate—psoriasis	0.000321	0.000526	CcSEcCtD
Hydroxocobalamin—Nausea—Prednisolone—psoriasis	0.00032	0.000524	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	0.00032	0.000822	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—NOS2—psoriasis	0.000318	0.000819	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Dexamethasone—psoriasis	0.000318	0.000521	CcSEcCtD
Hydroxocobalamin—Pruritus—Betamethasone—psoriasis	0.000318	0.000521	CcSEcCtD
Hydroxocobalamin—Skin disorder—Methotrexate—psoriasis	0.000318	0.000521	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signal transduction—STAT3—psoriasis	0.000317	0.000815	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—CAT—psoriasis	0.000313	0.000805	CbGpPWpGaD
Hydroxocobalamin—Nausea—Hydrocortisone—psoriasis	0.000313	0.000512	CcSEcCtD
Hydroxocobalamin—Rash—Triamcinolone—psoriasis	0.000313	0.000512	CcSEcCtD
Hydroxocobalamin—MMAB—Disease—APOE—psoriasis	0.000313	0.000804	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—APOE—psoriasis	0.000313	0.000804	CbGpPWpGaD
Hydroxocobalamin—Dermatitis—Triamcinolone—psoriasis	0.000312	0.000511	CcSEcCtD
Hydroxocobalamin—Urticaria—Prednisone—psoriasis	0.000311	0.000509	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—HLA-A—psoriasis	0.000311	0.0008	CbGpPWpGaD
Hydroxocobalamin—Headache—Triamcinolone—psoriasis	0.000311	0.000508	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Prednisone—psoriasis	0.00031	0.000507	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Dexamethasone—psoriasis	0.000308	0.000504	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Betamethasone—psoriasis	0.000308	0.000504	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	0.000308	0.000791	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—NFKB1—psoriasis	0.000303	0.000778	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Betamethasone—psoriasis	0.000298	0.000487	CcSEcCtD
Hydroxocobalamin—Dizziness—Dexamethasone—psoriasis	0.000298	0.000487	CcSEcCtD
Hydroxocobalamin—Nausea—Triamcinolone—psoriasis	0.000295	0.000482	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—STAT3—psoriasis	0.000294	0.000756	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Methotrexate—psoriasis	0.000292	0.000478	CcSEcCtD
Hydroxocobalamin—TCN1—Disease—NOS2—psoriasis	0.000291	0.000749	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—NOS2—psoriasis	0.000291	0.000749	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—APOE—psoriasis	0.000291	0.000747	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—SOCS1—psoriasis	0.00029	0.000745	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Prednisone—psoriasis	0.000289	0.000472	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Methotrexate—psoriasis	0.000288	0.000472	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by PDGF—STAT3—psoriasis	0.000287	0.000739	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—APOE—psoriasis	0.000286	0.000736	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—TYK2—psoriasis	0.000286	0.000735	CbGpPWpGaD
Hydroxocobalamin—Rash—Betamethasone—psoriasis	0.000284	0.000464	CcSEcCtD
Hydroxocobalamin—Rash—Dexamethasone—psoriasis	0.000284	0.000464	CcSEcCtD
Hydroxocobalamin—Dermatitis—Betamethasone—psoriasis	0.000283	0.000464	CcSEcCtD
Hydroxocobalamin—Dermatitis—Dexamethasone—psoriasis	0.000283	0.000464	CcSEcCtD
Hydroxocobalamin—CASP9—Apoptosis—TNF—psoriasis	0.000283	0.000727	CbGpPWpGaD
Hydroxocobalamin—Gastrointestinal disorder—Methotrexate—psoriasis	0.000283	0.000463	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—ITGAL—psoriasis	0.000283	0.000727	CbGpPWpGaD
Hydroxocobalamin—Headache—Betamethasone—psoriasis	0.000282	0.000461	CcSEcCtD
Hydroxocobalamin—Headache—Dexamethasone—psoriasis	0.000282	0.000461	CcSEcCtD
Hydroxocobalamin—Pain—Methotrexate—psoriasis	0.00028	0.000458	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	0.000279	0.000718	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—CAT—psoriasis	0.000279	0.000718	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—CAT—psoriasis	0.000279	0.000718	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—SOCS1—psoriasis	0.000278	0.000715	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HLA-A—psoriasis	0.000277	0.000713	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HLA-A—psoriasis	0.000277	0.000713	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Prednisone—psoriasis	0.000277	0.000454	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—NOS2—psoriasis	0.000271	0.000696	CbGpPWpGaD
Hydroxocobalamin—Feeling abnormal—Methotrexate—psoriasis	0.00027	0.000442	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Prednisone—psoriasis	0.000268	0.000439	CcSEcCtD
Hydroxocobalamin—MTR—Metabolism—CARM1—psoriasis	0.000267	0.000688	CbGpPWpGaD
Hydroxocobalamin—Nausea—Betamethasone—psoriasis	0.000267	0.000437	CcSEcCtD
Hydroxocobalamin—Nausea—Dexamethasone—psoriasis	0.000267	0.000437	CcSEcCtD
Hydroxocobalamin—MUT—Metabolism—CAT—psoriasis	0.000266	0.000685	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TNF—psoriasis	0.000265	0.000682	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HLA-A—psoriasis	0.000265	0.000681	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—REL—psoriasis	0.000264	0.00068	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—APOE—psoriasis	0.000262	0.000673	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—APOE—psoriasis	0.000262	0.000673	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—TYK2—psoriasis	0.000261	0.000671	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—STAT3—psoriasis	0.00026	0.000669	CbGpPWpGaD
Hydroxocobalamin—Urticaria—Methotrexate—psoriasis	0.00026	0.000426	CcSEcCtD
Hydroxocobalamin—Dizziness—Prednisone—psoriasis	0.000259	0.000424	CcSEcCtD
Hydroxocobalamin—AMN—Disease—APOE—psoriasis	0.000259	0.000666	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—APOE—psoriasis	0.000259	0.000666	CbGpPWpGaD
Hydroxocobalamin—Body temperature increased—Methotrexate—psoriasis	0.000259	0.000424	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—IFIH1—psoriasis	0.000257	0.00066	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—TP53—psoriasis	0.000255	0.000655	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TP53—psoriasis	0.000249	0.000641	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PPARG—psoriasis	0.000249	0.000641	CbGpPWpGaD
Hydroxocobalamin—Rash—Prednisone—psoriasis	0.000247	0.000404	CcSEcCtD
Hydroxocobalamin—MUT—Disease—APOE—psoriasis	0.000247	0.000635	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—HLA-B—psoriasis	0.000247	0.000635	CbGpPWpGaD
Hydroxocobalamin—Dermatitis—Prednisone—psoriasis	0.000247	0.000404	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD8A—psoriasis	0.000247	0.000634	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—IL6—psoriasis	0.000246	0.000633	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—CAT—psoriasis	0.000246	0.000632	CbGpPWpGaD
Hydroxocobalamin—Headache—Prednisone—psoriasis	0.000246	0.000402	CcSEcCtD
Hydroxocobalamin—CUBN—Disease—HLA-A—psoriasis	0.000244	0.000628	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—APOE—psoriasis	0.000243	0.000626	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-C—psoriasis	0.000243	0.000626	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—NOS2—psoriasis	0.000241	0.000621	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—NOS2—psoriasis	0.000241	0.000621	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Methotrexate—psoriasis	0.000241	0.000395	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—TNFAIP3—psoriasis	0.00024	0.000618	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	0.000239	0.000616	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—TYK2—psoriasis	0.000239	0.000613	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—TYK2—psoriasis	0.000239	0.000613	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HLA-B—psoriasis	0.000237	0.00061	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—CD4—psoriasis	0.000236	0.000607	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—IL6—psoriasis	0.000236	0.000606	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TP53—psoriasis	0.000234	0.000601	CbGpPWpGaD
Hydroxocobalamin—Nausea—Prednisone—psoriasis	0.000233	0.000381	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by ERBB4—IL6—psoriasis	0.000232	0.000596	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Methotrexate—psoriasis	0.000232	0.000379	CcSEcCtD
Hydroxocobalamin—MUT—Disease—NOS2—psoriasis	0.00023	0.000592	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—APOE—psoriasis	0.000228	0.000586	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PPARG—psoriasis	0.000228	0.000586	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PPARG—psoriasis	0.000228	0.000586	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Methotrexate—psoriasis	0.000224	0.000367	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by NGF—NFKB1—psoriasis	0.000223	0.000573	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—TYK2—psoriasis	0.000222	0.00057	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—IL6—psoriasis	0.000221	0.00057	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—IL6—psoriasis	0.00022	0.000567	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HLA-A—psoriasis	0.00022	0.000565	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—IL6—psoriasis	0.000219	0.000564	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CRP—psoriasis	0.000218	0.000562	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—IL6—psoriasis	0.000218	0.000561	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—APOE—psoriasis	0.000217	0.000558	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—APOE—psoriasis	0.000217	0.000558	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Methotrexate—psoriasis	0.000217	0.000354	CcSEcCtD
Hydroxocobalamin—TCN1—Disease—CD4—psoriasis	0.000216	0.000555	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—CD4—psoriasis	0.000216	0.000555	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NOS2—psoriasis	0.000212	0.000546	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PPARG—psoriasis	0.000212	0.000545	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	0.000211	0.000543	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—APOE—psoriasis	0.000207	0.000532	CbGpPWpGaD
Hydroxocobalamin—Rash—Methotrexate—psoriasis	0.000207	0.000338	CcSEcCtD
Hydroxocobalamin—Dermatitis—Methotrexate—psoriasis	0.000206	0.000338	CcSEcCtD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	0.000205	0.000528	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—IL6—psoriasis	0.000205	0.000528	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—IL6—psoriasis	0.000205	0.000528	CbGpPWpGaD
Hydroxocobalamin—Headache—Methotrexate—psoriasis	0.000205	0.000336	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR—IL6—psoriasis	0.000203	0.000523	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-E—psoriasis	0.000202	0.000519	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CAT—psoriasis	0.000202	0.000519	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—IL6—psoriasis	0.000202	0.000519	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HLA-DRB1—psoriasis	0.000201	0.000516	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—IL6—psoriasis	0.000201	0.000516	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—CD4—psoriasis	0.000201	0.000516	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HLA-A—psoriasis	0.000201	0.000516	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—STAT3—psoriasis	0.0002	0.000515	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—NFKBIA—psoriasis	0.000199	0.000512	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCL20—psoriasis	0.000198	0.000509	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—TYK2—psoriasis	0.000198	0.000508	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—TYK2—psoriasis	0.000198	0.000508	CbGpPWpGaD
Hydroxocobalamin—Nausea—Methotrexate—psoriasis	0.000195	0.000318	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—ICAM1—psoriasis	0.000193	0.000496	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NFKBIA—psoriasis	0.000191	0.000492	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—APOE—psoriasis	0.000191	0.000491	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PPARG—psoriasis	0.000189	0.000486	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PPARG—psoriasis	0.000189	0.000486	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—TYK2—psoriasis	0.000189	0.000485	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—APOE—psoriasis	0.000187	0.000481	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—STAT3—psoriasis	0.000183	0.00047	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	0.000182	0.000468	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PPARG—psoriasis	0.00018	0.000463	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CD4—psoriasis	0.000179	0.00046	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CD4—psoriasis	0.000179	0.00046	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NOS2—psoriasis	0.000174	0.000449	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—TYK2—psoriasis	0.000174	0.000447	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CD4—psoriasis	0.000171	0.000439	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—SOCS1—psoriasis	0.000169	0.000434	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—STAT3—psoriasis	0.000167	0.00043	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—STAT3—psoriasis	0.000167	0.00043	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PPARG—psoriasis	0.000166	0.000428	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CAT—psoriasis	0.000165	0.000423	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HLA-A—psoriasis	0.000163	0.00042	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—TYK2—psoriasis	0.000163	0.000419	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CD4—psoriasis	0.000157	0.000405	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—APOE—psoriasis	0.000157	0.000403	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—STAT3—psoriasis	0.000155	0.000399	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—APOE—psoriasis	0.000153	0.000392	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD8A—psoriasis	0.00015	0.000385	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CD4—psoriasis	0.000147	0.000379	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-B—psoriasis	0.000144	0.00037	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TYK2—psoriasis	0.000143	0.000367	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NOS2—psoriasis	0.000142	0.000366	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD4—psoriasis	0.000142	0.000364	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—IL6—psoriasis	0.00014	0.00036	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—STAT3—psoriasis	0.000138	0.000356	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—STAT3—psoriasis	0.000138	0.000356	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PPARG—psoriasis	0.000137	0.000351	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-A—psoriasis	0.000133	0.000343	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—STAT3—psoriasis	0.000132	0.00034	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—JUN—psoriasis	0.000132	0.000339	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CD4—psoriasis	0.000129	0.000332	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—APOE—psoriasis	0.000128	0.000329	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—IL6—psoriasis	0.000128	0.000328	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CRP—psoriasis	0.000127	0.000327	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—NFKB1—psoriasis	0.000127	0.000327	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HLA-A—psoriasis	0.000123	0.000317	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NFKB1—psoriasis	0.000122	0.000314	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—STAT3—psoriasis	0.000122	0.000313	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-DRB1—psoriasis	0.000122	0.000313	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ICAM1—psoriasis	0.000117	0.000301	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—IL6—psoriasis	0.000117	0.0003	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—IL6—psoriasis	0.000117	0.0003	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TYK2—psoriasis	0.000116	0.0003	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NFKBIA—psoriasis	0.000116	0.000298	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APOE—psoriasis	0.000115	0.000295	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PPARG—psoriasis	0.000111	0.000286	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SOCS1—psoriasis	0.000109	0.00028	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—IL6—psoriasis	0.000108	0.000279	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOS2—psoriasis	0.000107	0.000275	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CD4—psoriasis	0.000105	0.000271	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—STAT3—psoriasis	0.0001	0.000257	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—IL6—psoriasis	9.67e-05	0.000249	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—IL6—psoriasis	9.67e-05	0.000249	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—TYK2—psoriasis	9.5e-05	0.000244	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—IL6—psoriasis	9.22e-05	0.000237	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IFNG—psoriasis	8.89e-05	0.000229	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TYK2—psoriasis	8.77e-05	0.000226	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD4—psoriasis	8.59e-05	0.000221	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—IL6—psoriasis	8.51e-05	0.000219	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—STAT3—psoriasis	8.16e-05	0.00021	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—LEP—psoriasis	8.05e-05	0.000207	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APOE—psoriasis	8.05e-05	0.000207	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IL6—psoriasis	7.98e-05	0.000205	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CD4—psoriasis	7.93e-05	0.000204	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—JUN—psoriasis	7.69e-05	0.000198	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NFKBIA—psoriasis	7.5e-05	0.000193	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NFKB1—psoriasis	7.4e-05	0.00019	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—IL6—psoriasis	6.99e-05	0.00018	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—STAT3—psoriasis	6.65e-05	0.000171	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TYK2—psoriasis	6.14e-05	0.000158	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—STAT3—psoriasis	6.14e-05	0.000158	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IL6—psoriasis	5.7e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCL8—psoriasis	5.35e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—JUN—psoriasis	4.97e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NFKB1—psoriasis	4.79e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL6—psoriasis	4.65e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—psoriasis	4.34e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STAT3—psoriasis	4.3e-05	0.000111	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IL6—psoriasis	4.29e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—psoriasis	3.28e-05	8.44e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL6—psoriasis	3e-05	7.72e-05	CbGpPWpGaD
